Philippines consults on adopting WHO approach to registering biosimilars
This article was originally published in SRA
Executive Summary
The Philippines Food and Drug Administration is inviting feedback on its plans to adopt and implement the World Health Organization's 2009 guidance on the registration of biosimilar products1-4.